Skip to Main Content
  • Community
Try STAT+ TODAY
STAT
  • Log In
  • Try STAT+ Today
  • My Account
  • Billing
  • Log Out
Try STAT+ My Account
    • Biotech
    • Business
    • Coronavirus
    • Health
    • Health Tech
    • Hospitals
    • In the Lab
    • Insurance
    • Pharma
    • Politics & Policy
    • First Opinion
    • The Pharmalot View
    • Adam's Take
    • Matt's Take
    • Off the Charts
  • TEAM
    • Upcoming Industry Events
    • STAT Events
    • STAT Summits
  • NEWSLETTERS
    • Color Code
    • First Opinion Podcast
    • The Readout LOUD
    • STAT Trials Pulse
    • Reports
    • E-books
  • VIDEO
    • STAT+

      Exclusive analysis of biotech, pharma, and the life sciences

      Learn More
      • View Stories
      • My Account
    • Topics

      • Biotech
      • Pharma
      • Policy
      • Health Tech
      • Business
    • Columns

      • Adam's Take
      • Matt's Take
      • The Pharmalot View
    • Tools

      • CRISPR Trackr
      • Breakthrough Device Tracker
      • Drug Pricing Policy Cheat Sheet
    • Events

      • All STAT Events
    • Team

      • Biotech and Pharma
      • Health Tech
      • Politics and Policy
      • Health and Science

Account

  • My Account
  • Billing
  • Subscribe
  • Log In
  • Help

More

  • Community
  • Contribute
  • Group Subscriptions

Follow Us

Trending:
The Obesity Revolution
STAT+
Health
Biotech
In the Lab

MIT’s Susan Lindquist, a pioneer in science, dies at 67

By Bryan Marquard — Boston GlobeOct. 31, 2016

Reprints
Susan Lindquist ROBERT SPENCER/NEW YORK TIMES/FILE 2007

MIT’s Susan Lindquist, 67, a pioneer in science

About the Author Reprints

Bryan Marquard — Boston Globe

[email protected]
@bryanmarquard

Tags

Alzheimer’s

MIT

protein folding

Trending

Researchers devise new strategies to overcome a key CRISPR…
Researchers devise new strategies to overcome a key CRISPR flaw
Stéphane Bancel, Bernie Sanders spar over what Moderna owes…
Stéphane Bancel, Bernie Sanders spar over what Moderna owes the federal government
Stanford scientist who broke genome sequencing record on what…
Stanford scientist who broke genome sequencing record on what faster diagnoses mean for patients

Recommended

Researchers devise new strategies to overcome a key CRISPR…
Researchers devise new strategies to overcome a key CRISPR flaw
‘That is my dream’: Scientist who uncovered likely leading…
‘That is my dream’: Scientist who uncovered likely leading cause of MS wants to tackle ALS…
National Academies calls for transforming use of racial and…
National Academies calls for transforming use of racial and ethnic labels in genetics research

Recommended Stories

Biotech Adam Feuerstein

STAT Plus: FDA advisory panel recommends conditional approval of Biogen’s drug for rare form of ALS

Pharmalot Ed Silverman

Drugmakers push back on a clever tactic employers use to avoid paying for specialty medicines

advertisement

Health Tech Brittany Trang and Casey Ross

STAT Plus: ‘We’re getting much more aggressive’: Microsoft’s Nuance adds GPT-4 AI to its medical note-taking tool

Hospitals Bob Herman

STAT Plus: Hospitals are not crumbling, Medicare experts tell Congress

A STAT Investigation Casey Ross and Bob Herman

STAT Plus: Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need

STAT

Reporting from the frontiers of health and medicine

Trending:
  • The Obesity Revolution
  • STAT+
  • Health
  • Biotech
  • Pharmalot
  • First Opinion
Back to top

Company

  • About STAT
  • Awards
  • Contact Us
  • Careers & Internships
  • Diversity & Inclusion
  • Licensing Stories
  • Our Team
  • Supporters

Account

  • About STAT+
  • FAQs
  • Log In
  • Subscribe

App & Other Products

  • STAT App
  • Newsletters
  • Podcasts
  • STAT Madness
  • STAT Reports
  • STAT Trials Pulse
  • STAT Wunderkinds

Group Subscriptions

  • Contact Us
  • Request A Quote

Advertising

  • Advertise With Us

Events

  • Upcoming Industry Events
  • STAT Events
  • STAT Summits
  • Sponsor An Event
  • Privacy
  • Comment Policy
  • Terms
  • Do Not Sell my Data
  • ©2023 STAT

You've been selected! Subscribe to STAT+ for less than $2 per day

You've been selected! STAT+ for less than $2/day

Unlimited access to essential biotech, medicine, and life sciences journalism

Start your free trial

Subscribe to STAT+ for less than $2 per day

Subscribe to STAT+ for less than $2 per day

Unlimited access to the health care news and insights you need

Get unlimited access

Subscribe to STAT+ for less than $2 per day

Subscribe to STAT+ for less than $2 per day

Unlimited access to essential biotech, medicine, and life sciences journalism

Start your free trial